Robert J Bitterman Phio Pharmaceuticals Corp. (PHIO) insider trading activity

Robert J Bitterman is Chairman, Pres & CEO of Phio Pharmaceuticals Corp.. Currently has a direct ownership of 17,832 shares of PHIO, which is worth approximately $32,632. The most recent transaction as insider was on Sep 11, 2024, when has been sold 15,500 shares (Common Stock, $0.0001 par value) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 17.8K

0% 3M change

2.53% 12M change

Total Value Held $32,632

Robert J Bitterman Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 11 2024	BUY Grant, award, or other acquisition	-	15,500 Added 46.5%	17,832 Common Stock, $0.0001 ...
Jun 07 2024	BUY Open market or private purchase	$740 $0.74 p/Share	1,000 Added 4.55%	20,990 Common Stock, $0.0001 ...
Jun 06 2024	BUY Open market or private purchase	$750 $0.75 p/Share	1,000 Added 4.76%	19,990 Common Stock, $0.0001 ...
Feb 26 2024	BUY Open market or private purchase	$2,275 $0.91 p/Share	2,500 Added 11.63%	18,990 Common Stock, $0.0001 ...
Feb 20 2024	SELL Payment of exercise price or tax liability	$1,371 $0.76 p/Share	1,804 Reduced 9.86%	16,490 Common Stock, $0.0001 ...
Oct 01 2023	SELL Payment of exercise price or tax liability	$1,384 $1.51 p/Share	917 Reduced 4.77%	18,294 Common Stock, $0.0001 ...
Jul 01 2023	BUY Open market or private purchase	$2,840 $2.84 p/Share	1,000 Added 4.95%	19,211 Common Stock, $0.0001 ...
Jun 30 2023	BUY Open market or private purchase	$2,880 $2.88 p/Share	1,000 Added 5.21%	18,211 Common Stock, $0.0001 ...
Feb 20 2023	BUY Grant, award, or other acquisition	-	11,000 Added 38.99%	17,211 Common Stock, $0.0001 ...
Dec 14 2022	BUY Open market or private purchase	$780 $0.39 p/Share	2,000 Added 2.61%	74,541 Common Stock, $0.0001 ...
Dec 07 2022	BUY Open market or private purchase	$780 $0.39 p/Share	2,000 Added 2.68%	72,541 Common Stock, $0.0001 ...
Dec 05 2022	BUY Open market or private purchase	$860 $0.43 p/Share	2,000 Added 2.76%	70,541 Common Stock, $0.0001 ...
Nov 29 2022	BUY Open market or private purchase	$86 $0.4 p/Share	215 Added 0.31%	68,541 Common Stock, $0.0001 ...
Nov 25 2022	BUY Open market or private purchase	$1,050 $0.42 p/Share	2,500 Added 3.53%	68,326 Common Stock, $0.0001 ...
Nov 16 2022	BUY Open market or private purchase	$1,750 $1750.0 p/Share	1 Added 50.0%	1 Series D Preferred Sto...
Oct 01 2022	BUY Grant, award, or other acquisition	-	40,000 Added 37.8%	65,826 Common Stock, $0.0001 ...
Feb 15 2022	BUY Grant, award, or other acquisition	-	10,000 Added 27.91%	25,826 Common Stock, $0.0001 ...
Mar 01 2021	BUY Grant, award, or other acquisition	-	10,000 Added 38.72%	15,826 Common Stock, $0.0001 ...

RJB

Robert J Bitterman

Chairman, Pres & CEO

Marlborough, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PHIO shares.

Notify only if

Value

Insider Trading

Get notified when an Phio Pharmaceuticals Corp. insider buys or sells PHIO shares.

Notify only if

Operation

Value

Type

News

Receive news related to Phio Pharmaceuticals Corp.

Track Activities on PHIO

Account